BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wu IT, Chuah SK, Lee CH, Liang CM, Lu LS, Kuo YH, Yen YH, Hu ML, Chou YP, Yang SC, Kuo CM, Kuo CH, Chien CC, Chiang YS, Chiou SS, Hu TH, Tai WC. Five-year sequential changes in secondary antibiotic resistance of Helicobacter pylori in Taiwan. World J Gastroenterol 2015; 21(37): 10669-10674 [PMID: 26457027 DOI: 10.3748/wjg.v21.i37.10669]
URL: https://www.wjgnet.com/1007-9327/full/v21/i37/10669.htm
Number Citing Articles
1
Seng-Kee Chuah, Chih-Ming Liang, Chen-Hsiang Lee, Shue-Shian Chiou, Yi-Chun Chiu, Ming-Luen Hu, Keng-Liang Wu, Lung-Sheng Lu, Yeh-Pin Chou, Kuo-Chin Chang, Chung-Huang Kuo, Chung-Mou Kuo, Tsung-Hui Hu, Wei-Chen Tai. A Randomized Control Trial Comparing 2 Levofloxacin-Containing Second-Line Therapies for Helicobacter pylori EradicationMedicine 2016; 95(19): e3586 doi: 10.1097/MD.0000000000003586
2
Azucena Arévalo, William Alberto Otero, Alba Alicia Trespalacios. Helicobacter pylori: resistencia múltiple en pacientes de Bogotá, ColombiaBiomédica 2019; 39: 125 doi: 10.7705/biomedica.v39i3.4437
3
Alessia Savoldi, Elena Carrara, David Y. Graham, Michela Conti, Evelina Tacconelli. Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization RegionsGastroenterology 2018; 155(5): 1372 doi: 10.1053/j.gastro.2018.07.007
4
Reza Khashei, Mahintaj Dara, Abdollah Bazargani, Kamran Bagheri Lankarani, Alireza Taghavi, Maryam Moeini, Behzad Dehghani, Maryam Sohrabi. High rate of A2142G point mutation associated with clarithromycin resistance among Iranian Helicobacter pylori clinical isolatesAPMIS 2016; 124(9): 787 doi: 10.1111/apm.12567
5
Tzung‐Shiun Wu, Ping‐I Hsu, Chao‐Hung Kuo, Huang‐Ming Hu, I‐Chen Wu, Sophie S.W. Wang, Yen‐Hsu Chen, Deng‐Chyang Wu, Wei‐Wen Su, Fu‐Chen Kuo. Comparison of 10‐day levofloxacin bismuth‐based quadruple therapy and levofloxacin‐based triple therapy for Helicobacter pyloriJournal of Digestive Diseases 2017; 18(9): 537 doi: 10.1111/1751-2980.12498
6
Min Lee, Ji Yang, Yoonjung Cho, Hyun Woo, Hye Kwon, Do Kim, Min Park, Cheol Moon, Min Yeon, Hyun Kim, Woo-Duck Seo, Sa-Hyun Kim, Jong-Bae Kim. Inhibitory Effects of Menadione on Helicobacter pylori Growth and Helicobacter pylori-Induced Inflammation via NF-κB InhibitionInternational Journal of Molecular Sciences 2019; 20(5): 1169 doi: 10.3390/ijms20051169
7
Lien-Chieh Lin, Tzu-Herng Hsu, Kuang-Wei Huang, Ka-Wai Tam. Nonbismuth concomitant quadruple therapy for <i>Helicobacter pylori</i> eradication in Chinese regions: A meta-analysis of randomized controlled trialsWorld Journal of Gastroenterology 2016; 22(23): 5445-5453 doi: 10.3748/wjg.v22.i23.5445
8
Ji Yeong Yang, Jong-Bae Kim, Pyeongjae Lee, Sa-Hyun Kim. Evodiamine Inhibits Helicobacter pylori Growth and Helicobacter pylori-Induced InflammationInternational Journal of Molecular Sciences 2021; 22(7): 3385 doi: 10.3390/ijms22073385
9
Xiao-Feng Luo, Jian-Hua Jiao, Wen-Yue Zhang, Han-Ming Pu, Bao-Jin Qu, Bing-Ya Yang, Min Hou, Min-Jun Ji. Establishment of a nested-ASP-PCR method to determine the clarithromycin resistance of <i>Helicobacter pylori</i>World Journal of Gastroenterology 2016; 22(25): 5822-5830 doi: 10.3748/wjg.v22.i25.5822
10
Mohammad Sholeh, Saeed Khoshnood, Taher Azimi, Jasem Mohamadi, Vahab Hassan Kaviar, Marzieh Hashemian, Somayeh Karamollahi, Nourkhoda Sadeghifard, Hedayat Heidarizadeh, Mohsen Heidary, Morteza Saki. The prevalence of clarithromycin-resistant Helicobacter pylori isolates: a systematic review and meta-analysisPeerJ 2023; 11: e15121 doi: 10.7717/peerj.15121
11
Chih-An Shih, Chang-Bih Shie, Wei-Chen Tai, Seng-Kee Chuah, Hsi-Chang Lee, Ping-I Hsu. Update on the second-line treatment ofHelicobacter pyloriinfection: a narrative reviewTherapeutic Advances in Gastroenterology 2023; 16 doi: 10.1177/17562848231192750
12
Joseph Opeolu Ashaolu, Yu-Jen Tsai, Chia-Chen Liu, Dar-Der Ji. Prevalence, diversity and public health implications of Helicobacter species in pet and stray dogsOne Health 2022; 15: 100430 doi: 10.1016/j.onehlt.2022.100430
13
Te-Fu Lin, Ping-I Hsu. Second-line rescue treatment of <i>Helicobacter pylori</i> infection: Where are we now?World Journal of Gastroenterology 2018; 24(40): 4548-4553 doi: 10.3748/wjg.v24.i40.4548
14
UEG Week 2018 Poster PresentationsUnited European Gastroenterology Journal 2018; 6(S8) doi: 10.1177/2050640618792819
15
Margarita Camorlinga-Ponce, Alejandro Gómez-Delgado, Emmanuel Aguilar-Zamora, Roberto C. Torres, Silvia Giono-Cerezo, Antonio Escobar-Ogaz, Javier Torres. Phenotypic and Genotypic Antibiotic Resistance Patterns in Helicobacter pylori Strains From Ethnically Diverse Population in MéxicoFrontiers in Cellular and Infection Microbiology 2021; 10 doi: 10.3389/fcimb.2020.539115
16
Agnes Tving Stauning, Rie Louise Møller Nordestgaard, Tove Havnhøj Frandsen, Leif Percival Andersen. Helicobacter pylori [Working Title]2018;  doi: 10.5772/intechopen.80662
17
Ping‐I Hsu, Feng‐Woei Tsay, John Y. Kao, Nan‐Jing Peng, Yan‐Hua Chen, Sheng‐Yeh Tang, Chao‐Hung Kuo, Sung‐Shuo Kao, Huay‐Min Wang, I‐Ting Wu, Chang‐Bih Shie, Seng‐Kee Chuah, Deng‐Chyang Wu. Tetracycline‐levofloxacin versus amoxicillin‐levofloxacin quadruple therapies in the second‐line treatment of Helicobacter pylori infectionHelicobacter 2021; 26(5) doi: 10.1111/hel.12840
18
Jennifer Li, Xian-Zhi Li. Efflux-Mediated Antimicrobial Resistance in Bacteria2016; : 489 doi: 10.1007/978-3-319-39658-3_19
19
Chih-Ming Liang, Wei-Chen Tai, Pin-I Hsu, Deng-Chyang Wu, Chao-Hung Kuo, Feng-Woey Tsay, Chia-Long Lee, Kuan-Yang Chen, Seng-Kee Chuah. Trend of changes in antibiotic resistance in Helicobacter pylori from 2013 to 2019: a multicentre report from TaiwanTherapeutic Advances in Gastroenterology 2020; 13: 175628482097699 doi: 10.1177/1756284820976990
20
Chao Ran Ji, Jing Liu, Yue Yue Li, Chen Qiao, Jun Yan Qu, Jun Nan Hu, Min Juan Lin, Rui Ji, Li Xiang Li, Xiu Li Zuo, Yan Qing Li. Susceptibility‐guided quadruple therapy is not superior to medication history‐guided therapy for the rescue treatment of Helicobacter pylori infection: A randomized controlled trialJournal of Digestive Diseases 2020; 21(10): 549 doi: 10.1111/1751-2980.12934
21
Ping-I Hsu, Feng-Woei Tsai, Sung-Shuo Kao, Wen-Hung Hsu, Jin-Shiung Cheng, Nan-Jing Peng, Kuo-Wang Tsai, Huang-Ming Hu, Yao-Kuang Wang, Seng-Kee Chuah, Angela Chen, Deng-Chyang Wu. Ten-Day Quadruple Therapy Comprising Proton Pump Inhibitor, Bismuth, Tetracycline, and Levofloxacin is More Effective than Standard Levofloxacin Triple Therapy in the Second-Line Treatment of Helicobacter pylori Infection: A Randomized Controlled TrialAmerican Journal of Gastroenterology 2017; 112(9): 1374 doi: 10.1038/ajg.2017.195
22
Hye Jin Kwon, Min Ho Lee, Hyun Woo Kim, Ji Yeong Yang, Hyun Jun Woo, Min Park, Cheol Moon, Sa-Hyun Kim, Jong-Bae Kim. Riboflavin Inhibits Growth of Helicobacter pylori by Down-regulation of polA and dnaB GenesBiomedical Science Letters 2020; 26(4): 288 doi: 10.15616/BSL.2020.26.4.288
23
Jiunn‐Wei Wang, Ping‐I Hsu, Ming‐Hong Lin, John Kao, Feng‐Woei Tsay, I‐Ting Wu, Chang‐Bih Shie, Deng‐Chyang Wu. The efficacy of culture‐guided versus empirical therapy with high‐dose proton pump inhibitor as third‐line treatment of Helicobacter pylori infection: A real‐world clinical experienceJournal of Gastroenterology and Hepatology 2022; 37(10): 1928 doi: 10.1111/jgh.15942
24
Sudhansubala Lenka, Ruchi Bhuyan. Management of H. pylori Induced Peptic ulcer – A Phytotherapeutic ApproachJournal of Pure and Applied Microbiology 2022; 16(3): 1530 doi: 10.22207/JPAM.16.3.36